Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Mitomycin C in open angle glaucoma surgery with previous failed glaucoma surgery].

Martínez García A1, Pérez García R

  • 1Complejo Hospitalario Universitario de Santiago de Compostela, La Coruña, España.

Archivos De La Sociedad Espanola De Oftalmologia
|January 11, 2001
PubMed
Summary

Trabeculectomy with mitomycin-C is effective for lowering intraocular pressure and reducing medication needs in patients with previously failed glaucoma surgery. This procedure achieved an 88.2% success rate with minimal complications.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[The Ahmed valve implant in complicated glaucoma].

Archivos de la Sociedad Espanola de Oftalmologia·2001
See all related articles

Area of Science:

  • Ophthalmology
  • Glaucoma Surgery
  • Mitomycin-C Application

Context:

  • Glaucoma filtering surgery can fail, necessitating alternative treatment strategies.
  • Revisional glaucoma surgery presents unique challenges.
  • Mitomycin-C is an antifibrotic agent used to enhance surgical outcomes.

Purpose:

  • To evaluate the efficacy of trabeculectomy with intraoperative mitomycin-C in eyes with prior failed glaucoma filtering surgery.
  • To assess the impact on intraocular pressure (IOP) and medication requirements.
  • To determine the success rate and complication profile of this secondary filtering procedure.

Summary:

  • The study included 34 eyes of 26 patients with open-angle glaucoma and previous failed filtering surgeries.
  • Trabeculectomy with mitomycin-C resulted in a significant IOP decrease (from 21.06 mmHg to 13.88 mmHg) and a reduction in medication use (from 2.44 to 0.68).

Related Experiment Videos

  • The overall success rate was 88.2%, with hypotony maculopathy occurring in 8.8% of cases.

    • Impact:

    • Trabeculectomy augmented with mitomycin-C offers a viable solution for managing refractory glaucoma after initial surgical failure.
    • This approach effectively reduces IOP and medication burden, improving patient quality of life.
    • Understanding the success rates and potential complications is crucial for surgical planning and patient counseling.